Oral Thin Films Market value of US$ 6.6 Bn by the end of 2030

Bucillamine Thin Film Innovations Hold Promising Potentials in COVID-19 Treatment

Healthcare and pharmaceutical companies have been under pressure for drug innovations to treat coronavirus in patients. The introduction of COVID-19 vaccines by the Indian Government has lowered the pressure on pharmaceutical companies to launch drugs for the novel infection. Nevertheless, companies in the oral thin films market are increasing their R&D efforts. Revive Therapeutics— a specialist in life sciences, is carrying out R&D to explore the potentials of Bucillamine for thin film products that treat coronavirus.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111826

Moreover, in order to keep economies running, manufacturers in the oral thin films market are introducing product innovations using psilocybin and by collaborating with researchers. They are experimenting with a range of dosage forms using psilocybin, owing to its versatility through physio-chemical characterization, i.e. tensile strength of films.

Multiple Polymer-based Layers Overcome Thin Film Shortcomings

The oral thin films market is projected to reach the value of US$ 6.6 Bn by the end of 2030. However, it has been found that the small size of oral thin films leads to limited drug load capacities as compared to tablets and capsules. Hence, manufacturers are innovating in single and multiple polymer-based layers with the intended form of APIs (Active Pharmaceutical Ingredients).

On the other hand, manufacturers in the oral thin films market are faced with common misconceptions that these films can only carry aqueous soluble drugs. On the contrary, there are demonstrations that show the incorporation of poorly water soluble BCS II/IV drugs into orally disintegrating films that dissolve in the gastrointestinal (GI) tract.

Elongation at Break, Tear Resistance Form Important Factors for Manufacturing

Fast wetting, disintegration, and dissolution with large surface areas of oral thin films are translating into incremental opportunities for pharmaceutical companies. They are leveraging business opportunities to manage schizophrenia and migraine, since neurological conditions are estimated to dominate the highest revenue among all indication types in oral thin films market during the assessment period.

The oral thin films market is projected to advance at a robust CAGR of ~9% during the forecast period. Manufacturers are keeping in mind mechanical properties of drug eluting oral thin films, such as elongation at break and tear resistance, which are important factors for manufacturing, handling, and transportation. Companies are aiming to achieve precise dosing and flexibility in oral thin films so that they can be perforated and manipulated in size and thickness for the delivery of highly uniformed doses.

Supplement Dosage Administration Being Transformed by Indian Companies

Companies in the India oral thin films market are revolutionizing the way supplement dosage is administered in patients and individuals. Aavishkar Oral Strips, a Hyderabad-based company, is innovating in products that enable effective delivery mechanism of supplement dosage as per user convenience. Manufacturers in the global oral thin films market are taking cues from such companies to develop products that include active substances directly into the bloodstream. This improves bioavailability and makes it easier for controlled dosage.

Analysts’ Viewpoint

Apart from increasing R&D in oral strips to treat COVID-19, manufacturers are innovating in oral thin films that revolutionize supplement dosage, as an increasing number of individuals have adapted to a sedentary lifestyle. The quick and straightforward process of manufacturing oral strips as compared to tablets and capsules have grabbed the attention of pharmaceutical companies in the oral thin films market. However, there is a lack of knowledge and expertise to consistently generate a good product with homogeneity of API and desired pharmacokinetic profile. Hence, companies should increase their R&D to make improvements in manufacturing processes such as solvent casting and hot metal extrusion to consistently innovate in high quality oral strips.

Oral Thin Films Market: Overview

This report analyzes the current scenario and future prospects of the global oral thin films market. Rise in penetration of oral thin films in oral drug delivery systems and increase in the prevalence of dysphagia are key factors that are projected to drive the global oral thin films market during the forecast period.

The report includes an elaborate executive summary, which provides a snapshot of various segments of the global oral thin films market. It also provides information and data analysis of the oral thin films market with regards to segments based on product, indication, distribution channel, and region.

The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that impact the global oral thin films market

The report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the global oral thin films market

The report on the oral thin films market offers market attractiveness analysis of regions and segments

The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global oral thin films market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global oral thin films market.

Oral Thin Films Market: Key Segments

In terms of product, the global oral thin films market has been classified into sublingual film, fast dissolving oral film, and buccal film

Based on indication, the global oral thin films market has been categorized into pain management, neurological disorders, nausea & vomiting, opioid dependence, and others. The neurological disorders segment dominated the global oral thin films market in 2019, owing to higher incidence rate of neurological disorders, and increase in the prescription of oral thin films for the treatment of schizophrenia and opioid dependence.

In terms of distribution channel, the global oral thin films market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is expected to expand at a high CAGR from 2020 to 2030. Benefits such as convenience, discounted products, large number of options, and detailed product description offered by online pharmacies are likely to drive the segment during the forecast period.

Market size and forecast for each of these segments have been provided from 2018 to 2030. The CAGR of respective segment has also been provided from 2020 to 2030, considering 2019 as the base year.

Oral Thin Films Market: Regional Outlook

In terms of region, the global oral thin films market has been divided into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been further divided into countries/sub-regions.

The oral thin films market report provides size and forecast for each region and country/sub-region from 2018 to 2030. The CAGR for each of these regions and countries has also been provided for the forecast period from 2020 to 2030. The oral thin films market study also covers the competitive scenario in these regions.

Companies Covered in Oral Thin Films Market Report

Key players in the global oral thin films market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies

Major companies profiled in the oral thin films market report are

• ZIM Laboratories Limited
• Indivior plc
• Aquestive Therapeutics, Inc.
• LIVKON Pharmaceuticals pvt. Ltd.
• Shilpa Therapeutics Pvt. Ltd
• Sunovion Pharmaceuticals, Inc.
• NAL Pharma
• Cure Pharmaceutical
• IntelGenx Corp.
• Dr. Reddy’s Laboratories
• Kyu Pharmaceutical Co Ltd
• Seoul PharmaCo
• C.L. Pharm

Key Questions Answered in Oral Thin Films Market Report

• What are the major drivers, restraints, and opportunities in the market?
• What will be the Y-o-Y growth of the global oral thin films market between 2020 and 2030?
• What are the revenue share projections of key segments of the global oral thin films market during the forecast period?
• Which segment is likely to lead the global oral thin films market in terms of revenue by 2030?
• Will North America continue to be the most profitable market for oral thin films treatment?
• Which factors are anticipated to hamper the global oral thin films market during the forecast period?
• Which are the leading companies in the global oral thin films market?

Oral Thin Films Market – Segmentation

Product

• Sublingual Film
• Fast Dissolving Oral Film
• Buccal Film

Indication

• Pain Management
• Neurological Disorders
• Nausea & Vomiting
• Opioid Dependence
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111826/2900